Switch to:
NovaBay Pharmaceuticals Inc (AMEX:NBY)
EV/Revenue
21.87 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, NovaBay Pharmaceuticals Inc's enterprise value is $23.47 Mil. NovaBay Pharmaceuticals Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2014 was $1.07 Mil. Therefore, NovaBay Pharmaceuticals Inc's EV/Revenue ratio for today is 21.87.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, NovaBay Pharmaceuticals Inc's stock price is $0.63. NovaBay Pharmaceuticals Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2014 was $0.02. Therefore, NovaBay Pharmaceuticals Inc's P/S Ratio for today is 31.50.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NovaBay Pharmaceuticals Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=23.465/1.073
=21.87

NovaBay Pharmaceuticals Inc's current Enterprise Value is $23.47 Mil.
NovaBay Pharmaceuticals Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2014 was 0.51 (Dec. 2013 ) + 0.288 (Mar. 2014 ) + 0.123 (Jun. 2014 ) + 0.152 (Sep. 2014 ) = $1.07 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NovaBay Pharmaceuticals Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=0.63/0.02
=31.50

NovaBay Pharmaceuticals Inc's share price for today is $0.63.
NovaBay Pharmaceuticals Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was 0.01 (Dec. 2013 ) + 0.01 (Mar. 2014 ) + 0 (Jun. 2014 ) + 0 (Sep. 2014 ) = $0.02.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

NovaBay Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2rev 0.000.000.009.861.582.362.682.193.5812.03

NovaBay Pharmaceuticals Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2rev 4.203.413.585.816.0613.6412.0316.0913.8829.25
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK